• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Utah Medical Products Inc.

    5/28/25 1:40:34 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care
    Get the next $UTMD alert in real time by email
    SD 1 utmd_sd.htm UTAH MEDICAL PRODUCTS, INC. FORM SD UNITED STATES

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.  20549

     

    FORM SD

     

    SPECIALIZED DISCLOSURE REPORT

     

     

    UTAH MEDICAL PRODUCTS, INC.

    (Exact name of Registrant as specified in its charter)

     

     

    UTAH

    001-12575

    87-0342734

    (State or other jurisdiction

    (Commission File Number)

    (I.R.S. Employer

    of incorporation)

     

    Identification No.)

     

     

    7043 South 300 West

    Midvale, Utah  84047

    Address of principal executive offices

     

     

    Brian Koopman (801) 566-1200

    (Name and telephone number of the person to contact in connection with this report)

     

    xRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.  


     

    SECTION 1 – Conflict Minerals Disclosure

     

    Item 1.01 Conflict Minerals Disclosure and Report

    Utah Medical Products, Inc. (UTMD or the Company) manufactures and markets a broad range of disposable and reusable specialty medical devices, some of which contain necessary Conflict Minerals as described in SEC Rule 13p-1, namely gold, tantalum, tin, and tungsten. Accordingly, UTMD undertook a good-faith Reasonable Country of Origin Inquiry (RCOI), which was designed to determine whether any of the Conflict Minerals in its products originated in the Democratic Republic of Congo and adjoining countries (Covered Countries) and whether any of the Conflict Minerals may be from recycled or scrap sources.

     

    The Company does not purchase any Conflict Minerals for its products or components within its products directly from mines, smelters or refiners. Rather, the Company contracts with various suppliers to manufacture or supply its products or components. UTMD must therefore rely on its suppliers to provide information regarding the origin of the Conflict Minerals.

     

    Conflict Minerals Disclosure

    Based on its RCOI, UTMD has no reason to believe that any of its necessary Conflict Minerals may have originated in the Covered Countries.  

     

    To arrive at this determination, UTMD evaluated each of its products and identified those products and components that potentially contained a Conflict Mineral. Each supplier of those products or components was contacted and information about any Conflict Minerals within the product or component and the origin of those Conflict Minerals requested. In each instance where a product or component contained a Conflict Mineral, the supplier identified the origin as other than one of the Covered Countries.

     

    A copy of this Conflict Minerals Report is available on UTMD’s website at www.utahmed.com/conflictminerals.htm.

     

     

    Item 1.02 Exhibit

    Not applicable.

     

    SECTION 2 – Exhibits

    Not applicable


     

     

    SIGNATURES

     

     

    Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

     

     

     

     

    UTAH MEDICAL PRODUCTS, INC.

     

     

     

    REGISTRANT

     

     

     

     

     

     

     

     

     

     

    Date:

    5/28/2025

     

    By:

    /s/ Kevin L. Cornwell

     

     

     

     

    Kevin L. Cornwell

     

     

     

     

    CEO

     

    Get the next $UTMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UTMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UTMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the Board believes her robust understanding of the functional and strategic challenges that the Company faces will be integral for achieving future revenue growth.In addition, the Board of Directors appr

    11/5/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

    SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Overview of ResultsThe following is a summary comparison of 3Q and 9M of calendar 2024 with 3Q and 9M 2023 income statement mea

    10/29/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products, Inc. Announces Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtain

    8/2/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Leigh Carrie claimed ownership of 51 shares (SEC Form 3)

    3 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    11/12/24 9:51:55 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Principal Financial Officer Koopman Brian

    4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    11/8/24 11:58:20 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Principal Financial Officer Koopman Brian gifted 50 shares, decreasing direct ownership by 5% to 882 units (SEC Form 4)

    4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    7/22/24 4:56:33 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    SEC Filings

    View All

    SEC Form 10-Q filed by Utah Medical Products Inc.

    10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)

    8/12/25 3:51:42 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)

    7/24/25 2:03:58 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Utah Medical Products Inc.

    SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    7/15/25 4:03:17 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Financials

    Live finance-specific insights

    View All

    UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

    SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Overview of ResultsThe following is a summary comparison of 3Q and 9M of calendar 2024 with 3Q and 9M 2023 income statement mea

    10/29/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products, Inc. Announces Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtain

    8/2/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024

    SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (NASDAQ:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results which reflect a substantial decline in revenues.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. Because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results

    7/25/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/12/24 6:02:32 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/12/24 10:34:17 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/4/24 2:00:49 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Leadership Updates

    Live Leadership Updates

    View All

    Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the Board believes her robust understanding of the functional and strategic challenges that the Company faces will be integral for achieving future revenue growth.In addition, the Board of Directors appr

    11/5/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care